APP and familial Alzheimer disease: The remaining 5%—familial AD (fAD)—consists of patients who manifest the disease in their thirties, forties or fifties and carry genetic mutations in three genes (as currently known): amyloid precursor protein (APP), presenilin-1 (PS-1) and presenilin-2 (PS-2).